US Broker Ratings

ARS Pharmaceuticals (SPRY) Stock Analysis: Exploring a 250% Potential Upside in the Biotech Frontier

Investors with a keen eye on the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing opportunity. This San Diego-based biopharmaceutical company is making..

agilon health, inc. (AGL) Investor Outlook: Navigating a 59.24% Potential Upside Amidst Volatility

Investors eyeing the healthcare sector may find agilon health, inc. (NYSE: AGL) an intriguing yet challenging prospect. With a current market cap of $273.38 million, the..

National HealthCare Corporation (NHC) Stock Analysis: Evaluating the Healthcare Giant’s 12.5% Revenue Growth

National HealthCare Corporation (NHC), with a market cap of $2.03 billion, is a notable player in the U.S. healthcare sector, specifically within the medical care facilities..

Opko Health, Inc. (OPK) Investor Outlook: Exploring a 167% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Opko Health, Inc. (NASDAQ: OPK) presents a compelling case, driven by its expansive operations in diagnostics and pharmaceuticals...

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Navigating a 23.79% Upside Potential for Investors

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a prominent player in the specialty and generic drug manufacturing sector, with a diverse portfolio that includes a broad range..

Kestra Medical Technologies (KMTS) Stock Analysis: Growth Potential in Wearable Medical Devices

Investors with a keen eye on the healthcare sector may want to explore the promising potential of Kestra Medical Technologies, Ltd. (KMTS), a burgeoning player in..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a Potential 41% Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, AdaptHealth Corp. (NASDAQ: AHCO) presents a compelling case with a potential upside of 41.34% based on current analyst..

Integra LifeSciences Holdings C (IART) Stock Analysis: Exploring a 27% Upside Potential Amidst Challenging Metrics

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent name in the healthcare sector, particularly within the medical devices industry, has recently captured investor interest due to..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Revenue Growth and Analyst Confidence in Focus

Establishment Labs Holdings Inc (NASDAQ: ESTA) is drawing attention in the healthcare sector, particularly within the medical devices industry. Known for its innovative silicone gel-filled breast..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 117% Upside Potential in Biotechnology

Structure Therapeutics Inc. (NASDAQ: GPCR) has captured the attention of investors with its impressive potential upside of 117.24%, as indicated by analysts’ average target price of..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a 49.44% Potential Upside in the Healthcare Sector

In the dynamic world of drug manufacturing, HUTCHMED (China) Limited (NASDAQ: HCM) emerges as a noteworthy player with significant potential upside. With a compelling market capitalization..

Astrana Health Inc. (ASTH) Investor Outlook: Nearly 97% Potential Upside Amid Strong Buy Ratings

Astrana Health Inc. (NASDAQ: ASTH) is garnering significant attention from investors, driven by its substantial growth prospects and robust analyst endorsements. With a market capitalization of..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Strong Buy Ratings Amidst Promising Growth

As individual investors continue to navigate the dynamic landscape of the biotechnology sector, Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) presents a compelling case with its strategic focus..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Challenges with Innovative Solutions

10x Genomics, Inc. (NASDAQ: TXG) is at the forefront of the healthcare sector, specializing in health information services through its innovative life science technology. Headquartered in..

Alvotech (ALVO) Investor Outlook: Unpacking a 193.80% Potential Upside

Alvotech (NASDAQ: ALVO), a prominent player in the healthcare sector specializing in biosimilar medicines, has captured the attention of investors with a potential upside of 193.80%,..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A 45.75% Upside Potential Sparks Investor Interest

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, specifically in the medical care facilities industry, presents a compelling investment case with..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 28% Potential Upside Amidst Market Challenges

Neogen Corporation (NASDAQ: NEOG) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.38 billion,..

Concentra Group Holdings Parent (CON): Investor Outlook on a Potential 47.6% Upside and Robust Return on Equity

Concentra Group Holdings Parent, Inc. (CON) has emerged as an intriguing prospect for individual investors, particularly those focused on the healthcare sector. With a market capitalization..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring a Potential 86% Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a trailblazer in the biotechnology sector, has captured the attention of investors with its innovative approach to addressing diseases with high..

Indivior PLC (INDV)

❌ Error generating article: Server error: `POST https://api.openai.com/v1/chat/completions` resulted in a `520 ` response: error code: 520

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds